Biogen

Biogen

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$2,804,100
$2,736,000
$2,477,800
$2,279,300
Gross Profit
2,055,700
1,557,399
1,816,800
1,783,000
EBITDA
319,600
450,800
621,500
56,700
EBIT
78,500
214,700
417,100
-143,500
Net Income
-20,600
97,500
319,500
-48,411
Net Change In Cash
2,804,100
2,736,000
2,477,800
2,279,300
Free Cash Flow
600,400
489,800
696,700
555,900
Cash
1,303,900
1,285,000
3,382,700
3,008,500
Basic Shares
147,800
148,700
148,400
146,700

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$9,810,600
$9,675,900
$9,835,600
$10,173,400
Gross Profit
6,913,600
7,365,500
7,302,200
7,895,100
EBITDA
2,945,100
2,995,700
2,377,000
3,536,900
EBIT
2,165,200
2,322,500
1,882,200
3,018,500
Net Income
1,293,389
1,632,200
1,161,100
3,046,900
Net Change In Cash
9,810,600
9,675,900
9,835,600
10,173,400
Cost of Revenue
1,213,600
Free Cash Flow
2,050,800
2,515,700
1,235,800
1,144,000
Cash
3,008,500
2,375,000
1,049,900
3,419,300
Basic Shares
146,700
145,900
145,600
146,000

Earnings Calls

QuarterEPS
2026-09-30
$2.62
2026-06-30
$3.60
2026-03-31
$3.57
2025-12-31
$1.99